Bahrain becomes first country to approve AstraZeneca's antibody-based COVID-19 therapy
(VOVWORLD) - Bahrain was the first country in the world to approve the emergency use of AstraZeneca's antibody-based COVID-19 therapy called Evusheld (also known as AZD7442).










